A single dose, randomized, 5-period, balanced, crossover study to assess the relative bioavailability of three formulations and food effect on GSK364735 [S 364735] and pharmacokinetics following a double-blind, placebo controlled, repeat dose administration to healthy subjects.

Trial Profile

A single dose, randomized, 5-period, balanced, crossover study to assess the relative bioavailability of three formulations and food effect on GSK364735 [S 364735] and pharmacokinetics following a double-blind, placebo controlled, repeat dose administration to healthy subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jun 2012

At a glance

  • Drugs S 364735 (Primary)
  • Indications HIV infections
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 17 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top